Research Article| Volume 6, ISSUE 4, P195-199, October 1988

Topical minoxidil: Review of efficacy

  • H.Irving Katz
    Address for correspondence: H. Irving Katz, MD, Minnesota Clinical Study Center, 500 Osborne Road NE, Suite 250, Fridley, MN 55432.
    From, the Minnesota Clinical Study Center, Fridley, Minnesota USA
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.


      Hypertrichosis occurs as an undesirable adverse reaction in the majority of hypertensive patients treated with minoxidil (Loniten tablets, Upjohn Company, Kalamazoo, MI).1–3 Nevertheless, its potential topical use for the treatment of alopecia4 has caused much publicity and interest in several topical formulations of minoxidil recently available to selected patient populations. First, patients have participated in sanctioned Investigational New Drug studies using unique investigational formulations of The Upjohn Company. Secondly, patients have received Upjohn's topical 2% minoxidil solution marketed in a country outside of the United States, such as Canada. Lastly, patients have had a local pharmacist prepare an extemporaneous minoxidil solution from Loniten tablets.5,6
      The pharmacodynamics of such extemporaneous preparations are variable and may not be directly comparable to Upjohn's unique marketed product. Consequently in 1985, the Food and Drug Administration (FDA) issued an order to halt the use of Loniten Tablets for preparing extemporaneous topical minoxidil solutions for alopecia5; however, such nonapproved usage constituted by far the major route of exposure to topical minoxidil.7
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinics in Dermatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Burton JL
        • Marshall A
        Hypertrichosis due to minoxidil.
        Br J dermatol. 1979; 101: 593-595
        • Zappacosta AR
        Reversal of baldness in a patient receiving minoxidil for hypertension.
        N Engl J Med. 1980; 303: 1480-1481
        • Seidman M
        • Westfried M
        • Maxey R
        • et al.
        Reversal of male pattern baldness by minoxidil.
        Cutis. 1981; 28: 551-553
        • Weiss VC
        • West DP
        Topical minoxidil therapy and hair regrowth.
        Arch dermatol. 1985; 121: 191-192
      1. FDA Drug Bull. 1985; 15: 38
      2. J Am Acad dermatol. 1986; 14: 828-829
        • Stern RS
        Topical minoxidil.
        Arch dermatol. 1987; 123: 62-65
        • Tosti A
        Topical minoxidil useful in 18% of patients with androgenetic alopecia: a study of 430 cases.
        Dermatologica. 1986; 173: 136-138
        • Bergfeld W
        Minoxidil shows promise as hair growth agent in alopecia.
        Dermatology Times. April 1987; 8: 27
        • Novak E
        • Franz TJ
        • Headington JT
        • et al.
        Topically applied minoxidil in baldness.
        Int J dermatol. 1985; 24: 82-87
        • Vanderveen EE
        • Ellis CN
        • Kang S
        • et al.
        Topical minoxidil for hair regrowth.
        J Am Acad dermatol. 1984; 11: 416-421
        • Headington JT
        • Novak E
        Histological findings in androgenetic alopecia treated with topical minoxidil.
        Br J dermatol. 1982; 107: 20-21
      3. The Upjohn Company. Data on file.

        • DeVillez RL
        Topical minoxidil therapy in hereditary androgenetic alopecia.
        Arch dermatol. 1985; 121: 197-202
        • Olsen EA
        • Weiner MS
        • Delong ER
        • et al.
        Topical minoxidil in early male pattern baldness.
        J Am Acad dermatol. 1985; 13: 185-192
        • Storer JS
        • Brzuskiewicz J
        • Floyd H
        • et al.
        Topical minoxidil for male pattern baldness.
        Am J Med Sci. 1986; 291: 328-333
        • Hamilton JB
        Patterned loss of hair in man: types and incidence.
        Ann NY Acad Sci. 1951; 53: 708-728
        • Olsen EA
        • DeLong ER
        • Weiner MS
        Dose-response study of topical minoxidil in male pattern baldness.
        J Am Acad dermatol. 1986; 15: 30-37
        • Abell E
        • Cary MM
        The pathologic effect of minoxidil in male pattern alopecia.
        J Invest dermatol. 1986; 86: 459